Volume 17, Issue 6 (Nov-Dec 2023)                   mljgoums 2023, 17(6): 10-12 | Back to browse issues page

XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Shahbazi A E, Barati N, Soleymani E, Khandan Del P, Khandan Del A, Azizi N, et al . Association between toxoplasmosis and COVID-19 infection: A cross-sectional study. mljgoums 2023; 17 (6) :10-12
URL: http://mlj.goums.ac.ir/article-1-1575-en.html
1- School of Nursing and Midwifery, Saveh University of Medical Sciences, Saveh, Iran
2- Research Center for Molecular Medicine, Hamadan University of Medical Sciences, Hamadan, Iran
3- Department of Medical Parasitology and Mycology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran
4- Department of Microbiology, Gorgan Branch, Islamic AzadUniversity, Gorgan, Iran
5- Department of Microbiology, 5th Azar Hospital, Golestan University of Hospital, Golestan University of Medical Sciences, Gorgan, Iran
6- Department of Medical Parasitology and Mycology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran , m_motevali@umsha.ac.ir
Abstract:   (644 Views)
Background: COVID-19 is a respiratory disease pandemic and a major global health problem that can cause acute respiratory distress syndrome (ARDS). Previous studies have shown an inverse link between toxoplasmosis and COVID-19. This study aimed to evaluate the association between COVID-19 and toxoplasmosis infection.
Methods: In this cross-sectional descriptive study, samples were taken from 360 patients, 50% of whom were men and 50% were women. Of the patients, 180 were determined to be COVID-19-positive by the ELISA kit, and 180 were in the control group. Some demographic characteristics, such as sex, age range, and occupation, were also recorded.
Results: This study was conducted on 180 COVID-19-positive patients, of whom 26.7% were in the 16-30-year age group, 25.1% were self-employed, and 31.7% had anti-Toxoplasma gondii antibodies. Among the 180 control patients, 21.1% had antibodies for T. gondii. Of the 57 patients who were co-infected with both COVID-19 and toxoplasmosis, men had higher infection rates (63.2%) than women (36.8%). There was a significant relationship between co-infections with COVID-19 and toxoplasmosis with occupation, but not with age.
Conclusion: The study found that people with toxoplasmosis infection have a 1.73 times higher risk of contracting COVID-19. The findings suggest that infectious agents could be a predisposing factor, possibly due to changes in cytokine levels.
Full-Text [PDF 350 kb]   (241 Downloads) |   |   Full-Text (HTML)  (93 Views)  
Research Article: Research Article | Subject: Parasitology
Received: 2022/09/11 | Accepted: 2023/01/23 | Published: 2024/02/26 | ePublished: 2024/02/26

References
1. Wang Y, Wang Y, Chen Y, Qin Q. Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID‐19) implicate special control measures. Journal of medical virology. 2020;92(6):568-76. [View at Publisher] [DOI] [PMID] [Google Scholar]
2. Cao W. Clinical features and laboratory inspection of novel coronavirus pneumonia (COVID-19) in Xiangyang, Hubei. medRxiv. 2020. [View at Publisher] [DOI] [Google Scholar]
3. Manesh RM, Safa AH, Sharafi SM, Jafari R, Bahadoran M, Yousefi M, et al. Parasites and chronic renal failure. Journal of renal injury prevention. 2014;3(4):87. [View at Publisher] [Google Scholar]
4. Russell B, Moss C, George G, Santaolalla A, Cope A, Papa S, et al. Associations between immune-suppressive and stimulating drugs and novel COVID-19-a systematic review of current evidence. ecancermedicalscience. 2020;14. [View at Publisher] [DOI] [Google Scholar]
5. Slimano F, Baudouin A, Zerbit J, Toulemonde-Deldicque A, Thomas-Schoemann A, Chevrier R, et al. Cancer, immune suppression and Coronavirus Disease-19 (COVID-19): Need to manage drug safety (French Society for Oncology Pharmacy [SFPO] guidelines). Cancer treatment reviews. 2020;88. [View at Publisher] [DOI] [PMID] [Google Scholar]
6. Zadeh AE, Bamedi T, Etemadi S, Shahrakipour M, Saryazdipour K. Toxoplasmosis as a complication of transfusion in hemodialysis patients. Iranian journal of pediatric hematology and oncology. 2014;4(1):22. [View at Publisher] [Google Scholar]
7. Zhong J, Tang J, Ye C, Dong L. The immunology of COVID-19: is immune modulation an option for treatment? The Lancet Rheumatology. 2020. [View at Publisher] [DOI] [PMID] [Google Scholar]
8. Jankowiak Ł, Rozsa L, Tryjanowski P, Møller AP. Strong negative covariation between toxoplasmosis and CoVID-19 at a global scale: a spurious indirect effect? 2020. [View at Publisher] [DOI] [Google Scholar]
9. Alavi SM, Alavi L. Toxoplasmosis in Iran: A guide for general physicians working in the Iranian health network setting: A systematic review. Caspian Journal of Internal Medicine. 2016;7(4):233. [View at Publisher] [PMID] [Google Scholar]
10. Alghamdi J, Elamin MH, Alhabib S. Prevalence and genotyping of Toxoplasma gondii among Saudi pregnant women in Saudi Arabia. Saudi Pharmaceutical Journal. 2016;24(6):645-51. [View at Publisher] [DOI] [PMID] [Google Scholar]
11. Zeleke AJ, Melsew YA. Seroprevalence of Toxoplasma gondii and associated risk factors among HIV-infected women within reproductive age group at Mizan Aman General Hospital, Southwest Ethiopia: a cross sectional study. BMC Research Notes. 2017;10(1):70. [View at Publisher] [DOI] [PMID] [Google Scholar]
12. Maraghi S, Yadyad MJ, Sheikhi M, Shamakhteh F, Latifi SM. Study the anti-Toxoplasma antibodies (IgG and IgM) in hemodialysis patients of Abadan and Khoramshahr cities Southwest Iran in 2011 using ELISA. Jundishapur Journal of Microbiology. 2013;6(7). [View at Publisher] [DOI] [Google Scholar]
13. Motevalli Haghi SM, Fakhar M, Sharif M, Keyghobadi M. An overview on different diagnostic methods for babesiosis. Journal of Mazandaran University of Medical Sciences. 2014;23(109):283-95. [View at Publisher] [Google Scholar]
14. Norouzi M, TABAEI SJS, Niyyati M, Saber V, Behniafar H. Genotyping of Toxoplasma gondii Strains Isolated from Patients with Ocular Toxoplasmosis in Iran. Iranian Journal of Parasitology. 2016;11(3):316-24. [View at Publisher] [Google Scholar]
15. Motevalli Haghi SM, Najm M, Fakhar M, Gholami S, MotevalliHaghi S. Prevalence of Enterobius vermicularis infection among kindergartens of Sari and Babol cities during 2011. Journal of Mazandaran University of Medical Sciences. 2013;22(1):240-2. [View at Publisher] [Google Scholar]
16. Shen B, Yuan Y, Cheng J, Pan M, Xia N, Zhang W, et al. Activation of chronic toxoplasmosis by transportation stress in a mouse model. Oncotarget. 2016;7(52):87351-60. [View at Publisher] [DOI] [PMID] [Google Scholar]
17. Haghi MM, Khorshidvand Z, Khazaei S, Foroughi-Parvar F, Sarmadian H, Barati N, et al. Cryptosporidium animal species in Iran: a systematic review and meta-analysis. Tropical Medicine and Health. 2020;48(1):1-15. [View at Publisher] [DOI] [PMID] [Google Scholar]
18. Amany M, Eid R, Fahmy B. Biochemical studies on the effect of Toxoplasma infection on liver and kidney functions in mice. Egyptain Journal of Comparative Pathology and Clinical Pathology. 2010;23(1). [View at Publisher] [Google Scholar]
19. Gharavi M, Jalali S, Khademvatan S, Heydari S. Detection of IgM and IgG anti-Toxoplasma antibodies in renal transplant recipients using ELFA, ELISA and ISAGA methods: comparison of pre-and post-transplantation status. Annals of Tropical Medicine & Parasitology. 2011;105(5):367-71. [View at Publisher] [DOI] [PMID] [Google Scholar]
20. Shahbazi AE, Saidijam M, Maghsood AH, Matini M, Haghi MM, Fallah M. Genotyping of fresh and Parafinized human hydatid cysts using nad1 and cox1 genes in Hamadan Province, west of Iran. Iranian Journal of Parasitology. 2020;15(2):259. [View at Publisher] [DOI] [PMID] [Google Scholar]
21. Rawson TM, Moore LS, Zhu N, Ranganathan N, Skolimowska K, Gilchrist M, et al. Bacterial and fungal coinfection in individuals with coronavirus: a rapid review to support COVID-19 antimicrobial prescribing. Clinical Infectious Diseases. 2020;71(9):2459-68. [View at Publisher] [DOI] [PMID] [Google Scholar]
22. Chen X, Liao B, Cheng L, Peng X, Xu X, Li Y, et al. The microbial coinfection in COVID-19. Applied microbiology and biotechnology. 2020:1-9. [View at Publisher] [DOI] [PMID] [Google Scholar]
23. Ssebambulidde K, Segawa I, Abuga KM, Nakate V, Kayiira A, Ellis J, et al. Parasites and their protection against COVID-19-Ecology or Immunology? MedRxiv. 2020. [View at Publisher] [DOI] [Google Scholar]
24. Sharaf-El-Deen SA. Toxoplasma gondii as a possible risk factor for COVID-19 severity: a case-control study. Egyptian Journal of Medical Microbiology. 2021;30(2):125-32. [View at Publisher] [DOI] [Google Scholar]
25. Chiappelli F, Khakshooy A, Greenberg G. CoViD-19 immunopathology and immunotherapy. Bioinformation. 2020;16(3):219. [View at Publisher] [DOI] [PMID] [Google Scholar]
26. De Biasi S, Meschiari M, Gibellini L, Bellinazzi C, Borella R, Fidanza L, et al. Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia. Nature communications. 2020;11(1):1-17. [View at Publisher] [DOI] [PMID] [Google Scholar]
27. Winkler F, Bengsch B. Use of mass cytometry to profile human T cell exhaustion. Frontiers in immunology. 2020;10:3039. [View at Publisher] [DOI] [PMID] [Google Scholar]
28. Luo P, Liu Y, Qiu L, Liu X, Liu D, Li J. Tocilizumab treatment in COVID‐19: a single center experience. Journal of medical virology. 2020;92(7):814-8. [View at Publisher] [DOI] [PMID] [Google Scholar]
29. Dróżdż M, Krzyżek P, Dudek B, Makuch S, Janczura A, Paluch E. Current State of Knowledge about Role of Pets in Zoonotic Transmission of SARS-CoV-2. Viruses. 2021;13(6):1149. [View at Publisher] [DOI] [PMID] [Google Scholar]
30. Giraldo-Ramirez S, Rendon-Marin S, Jaimes JA, Martinez-Gutierrez M, Ruiz-Saenz J. SARS-CoV-2 clinical outcome in domestic and wild cats: A systematic review. Animals. 2021;11(7):2056. [View at Publisher] [DOI] [PMID] [Google Scholar]
31. Villanueva‐Saz S, Giner J, Tobajas AP, Pérez MD, González‐Ramírez AM, Macías‐León J, et al. Serological evidence of SARS‐CoV‐2 and co‐infections in stray cats in Spain. Transboundary and Emerging Diseases. 2021. [View at Publisher] [DOI] [PMID] [Google Scholar]
32. Michelitsch A, Schön J, Hoffmann D, Beer M, Wernike K. The Second Wave of SARS-CoV-2 Circulation-Antibody Detection in the Domestic Cat Population in Germany. Viruses. 2021;13(6):1009. [View at Publisher] [DOI] [PMID] [Google Scholar]
33. Flegr J. Toxoplasmosis is a risk factor for acquiring SARS-CoV-2 infection and a severe course of COVID-19 in the Czech and Slovak population: a preregistered exploratory internet cross-sectional study. Parasites & Vectors. 2021;14(1):1-11. [View at Publisher] [DOI] [PMID] [Google Scholar]
34. Levin AT, Hanage WP, Owusu-Boaitey N, Cochran KB, Walsh SP, Meyerowitz-Katz G. Assessing the age specificity of infection fatality rates for COVID-19: systematic review, meta-analysis, and public policy implications. European journal of epidemiology. 2020:1-16. [View at Publisher] [DOI] [Google Scholar]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2007 All Rights Reserved | Medical Laboratory Journal

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.